Abstract
Purpose: Usage of high-flow nasal cannula (HFNC) for bronchiolitis has become increasingly prevalent. However, the effectiveness of HFNC therapy remains controversial. Our goal was to characterize HFNC usage rates and patient outcomes for children hospitalized with bronchiolitis at our institution, and to inform quality improvement efforts to reduce potentially unnecessary HFNC usage. Design: Retrospective patient-level data was extracted from an automated Electronic Data Warehouse (EDW) linked to Epic, our electronic medical record, to determine rates of HFNC usage in bronchiolitis patients, with a smaller subset verified by manual chart review. Included patients were children …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
